You are here Home Guidance and resources Sponsors Nexo Pharmaceuticals Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Designation or determination (1) Prescription medicine evaluation (1) Date 2024 (1) 2023 (1) Results for "[search-keyword]" Search Sponsor content2 result(s) found, displaying 1 to 2 NexoBrid Nexo Pharmaceuticals Pty Ltd Jul-2024 Prescription medicine evaluation Active ingredient: anacaulase-bcdb. Notice for anacaulase-bcdb (Nexo Pharmaceuticals Pty Ltd) 28 August 2023 Designation or determination Orphan Drug
NexoBrid Nexo Pharmaceuticals Pty Ltd Jul-2024 Prescription medicine evaluation Active ingredient: anacaulase-bcdb.
Notice for anacaulase-bcdb (Nexo Pharmaceuticals Pty Ltd) 28 August 2023 Designation or determination Orphan Drug